Enhabit, Inc. $EHAB Shares Acquired by West Tower Group LLC

West Tower Group LLC increased its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 31.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 375,142 shares of the company’s stock after buying an additional 90,000 shares during the period. Enhabit comprises 8.7% of West Tower Group LLC’s portfolio, making the stock its 3rd largest holding. West Tower Group LLC owned 0.74% of Enhabit worth $3,005,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in EHAB. CWM LLC increased its position in Enhabit by 202.1% during the 3rd quarter. CWM LLC now owns 22,914 shares of the company’s stock worth $184,000 after purchasing an additional 15,330 shares in the last quarter. Osaic Holdings Inc. raised its holdings in Enhabit by 337.5% in the second quarter. Osaic Holdings Inc. now owns 2,616 shares of the company’s stock valued at $25,000 after buying an additional 2,018 shares during the period. Orion Porfolio Solutions LLC lifted its holdings in shares of Enhabit by 5.8% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 142,655 shares of the company’s stock valued at $1,375,000 after acquiring an additional 7,824 shares in the last quarter. State of Wyoming boosted its position in shares of Enhabit by 21.1% in the second quarter. State of Wyoming now owns 57,775 shares of the company’s stock worth $557,000 after buying an additional 10,068 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in Enhabit by 82.9% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,542 shares of the company’s stock worth $44,000 after acquiring an additional 2,059 shares during the period.

Enhabit Stock Performance

Shares of EHAB opened at $9.39 on Friday. Enhabit, Inc. has a 12 month low of $6.47 and a 12 month high of $10.90. The company’s fifty day moving average is $8.81 and its 200-day moving average is $8.24. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75. The firm has a market cap of $474.97 million, a price-to-earnings ratio of -37.54 and a beta of 1.67.

Enhabit (NYSE:EHAB) last posted its earnings results on Wednesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.05. Enhabit had a negative net margin of 1.14% and a positive return on equity of 3.91%. The business had revenue of $263.60 million for the quarter, compared to analyst estimates of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Equities analysts expect that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on EHAB shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enhabit in a research note on Monday. Citigroup restated a “buy” rating on shares of Enhabit in a research note on Tuesday, December 16th. Finally, Jefferies Financial Group restated a “buy” rating on shares of Enhabit in a research report on Tuesday, December 16th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $8.50.

Enhabit Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.